Speaking Engagements (Staff, Collaborators, Strategic Partners)
(R. John Glasspool) Duke-Margolis Center for Health Policy Workshop
(Kay Larholt) Real World Evidence Discussions & Overview of Related Projects
(Gigi Hirsch) Panel: Getting What You Measure: Incentives for Collaboration
(Mark Trusheim) Adaptive Pathways and Platform Trials Discussion
(Gigi Hirsch) Panel: Real World Evidence: Hype or Reality? (John Glasspool, Moderator)
(Mark Trusheim) Panel: Gene Therapy: Commercialization Readiness & Market Access Challenges
(Gigi Hirsch) Panel: Adaptive Biomedical Innovations: The Way Forward (Stella Blackburn, Moderator)
hosted by the National Cancer Policy Forum. (G.K. Raju)
“The Impact of a New Healthcare Model: What Do Payers Think of Gene Therapies?” (Mark Trusheim)
NBER Pre-Conference on Economic Dimensions of Personalized and Precision Medicine
“Europe and the US: Making Outcomes-Based Health Care Possible.” Details here. (Gigi Hirsch).
(Gigi Hirsch & Hans-Georg Eichler – Session Co-Chairs).
“Curative Therapies: Aligning Policy with Science to Ensure Patient Access” (Mark Trusheim).
“Adaptive Pathways and Biomedical Innovation in the EU, US and Japan” (Ken Oye).
“Adaptive Biomedical Innovation: Re-engineering How We Innovate” (Gigi Hirsch).
co-sponsored by Silicon Valley Executive Network (SVEN), Decision Resources Group, and MIT Media Lab. “Adaptive Biomedical Innovation: Transforming Big Data Hype into Patient Value” (Tom Unger).
Belgian Healthcare Knowledge Center (HKC) & WHO jointly sponsored Drug Pricing Scenarios Project (Report to be presented to Dutch EU Presidency in June 2016) – Part 1 (Mark Trusheim).
Panel Debate on “Earlier Access vs. Safety?” (Hans-Georg Eichler & Ken Oye).